Listed

Pacific Biosciences of California, Inc.

PACBNasdaqCIK 1299130TechnologyFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$39.0m, Q2 FY2026
Operating income−$44.6m, Q2 FY2026
Net income−$44.7m, Q2 FY2026
Pacific Biosciences of California, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m55.7Revenue, Q3 FY2023, three months to 2023-09-30$55.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure58.4Revenue, Q4 FY2023, three months to 2023-12-31$58.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure38.8Revenue, Q1 FY2024, three months to 2024-03-31$38.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure36.0Revenue, Q2 FY2024, three months to 2024-06-30$36.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure40.0Revenue, Q3 FY2024, three months to 2024-09-30$40.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure39.2Revenue, Q4 FY2024, three months to 2024-12-31$39.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure37.2Revenue, Q1 FY2025, three months to 2025-03-31$37.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure39.8Revenue, Q2 FY2025, three months to 2025-06-30$39.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure38.4Revenue, Q3 FY2025, three months to 2025-09-30$38.4m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure44.6Revenue, Q4 FY2025, three months to 2025-12-31$44.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure37.2Revenue, Q1 FY2026, three months to 2026-03-31$37.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure39.0Revenue, Q2 FY2026, three months to 2026-06-30$39.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Cost of revenue$m37.8Cost of revenue, Q3 FY2023, three months to 2023-09-30$37.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure48.8Cost of revenue, Q4 FY2023, three months to 2023-12-31$48.8m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure27.5Cost of revenue, Q1 FY2024, three months to 2024-03-31$27.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure30.1Cost of revenue, Q2 FY2024, three months to 2024-06-30$30.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure30.0Cost of revenue, Q3 FY2024, three months to 2024-09-30$30.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure29.2Cost of revenue, Q4 FY2024, three months to 2024-12-31$29.2m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure38.5Cost of revenue, Q1 FY2025, three months to 2025-03-31$38.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure25.1Cost of revenue, Q2 FY2025, three months to 2025-06-30$25.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure22.5Cost of revenue, Q3 FY2025, three months to 2025-09-30$22.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure28.1Cost of revenue, Q4 FY2025, three months to 2025-12-31$28.1m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure24.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$24.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure26.4Cost of revenue, Q2 FY2026, three months to 2026-06-30$26.4m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Gross profit$m17.9Gross profit, Q3 FY2023, three months to 2023-09-30$17.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure9.6Gross profit, Q4 FY2023, three months to 2023-12-31$9.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure11.3Gross profit, Q1 FY2024, three months to 2024-03-31$11.3m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure5.9Gross profit, Q2 FY2024, three months to 2024-06-30$5.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure10.0Gross profit, Q3 FY2024, three months to 2024-09-30$10.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure10.1Gross profit, Q4 FY2024, three months to 2024-12-31$10.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(1.4)Gross profit, Q1 FY2025, three months to 2025-03-31−$1.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure14.7Gross profit, Q2 FY2025, three months to 2025-06-30$14.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure15.9Gross profit, Q3 FY2025, three months to 2025-09-30$15.9m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure16.6Gross profit, Q4 FY2025, three months to 2025-12-31$16.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure12.8Gross profit, Q1 FY2026, three months to 2026-03-31$12.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure12.6Gross profit, Q2 FY2026, three months to 2026-06-30$12.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Research and development$m47.5Research and development, Q3 FY2023, three months to 2023-09-30$47.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure44.5Research and development, Q4 FY2023, three months to 2023-12-31$44.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure43.5Research and development, Q1 FY2024, three months to 2024-03-31$43.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure38.5Research and development, Q2 FY2024, three months to 2024-06-30$38.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure25.5Research and development, Q3 FY2024, three months to 2024-09-30$25.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure27.5Research and development, Q4 FY2024, three months to 2024-12-31$27.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure29.1Research and development, Q1 FY2025, three months to 2025-03-31$29.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure22.5Research and development, Q2 FY2025, three months to 2025-06-30$22.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure22.8Research and development, Q3 FY2025, three months to 2025-09-30$22.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure22.9Research and development, Q4 FY2025, three months to 2025-12-31$22.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure19.6Research and development, Q1 FY2026, three months to 2026-03-31$19.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure23.0Research and development, Q2 FY2026, three months to 2026-06-30$23.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Selling, general and administrative$m43.4Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$43.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure46.0Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$46.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure43.8Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$43.8m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure45.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$45.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure43.7Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$43.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure41.6Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$41.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure40.2Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$40.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure36.2Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$36.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure31.1Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$31.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure34.1Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$34.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure31.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$31.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure33.4Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$33.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Operating income$m(82.5)Operating income, Q3 FY2023, three months to 2023-09-30−$82.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure(87.5)Operating income, Q4 FY2023, three months to 2023-12-31−$87.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(81.4)Operating income, Q1 FY2024, three months to 2024-03-31−$81.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure(176)Operating income, Q2 FY2024, three months to 2024-06-30−$175.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure(64.1)Operating income, Q3 FY2024, three months to 2024-09-30−$64.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure(153)Operating income, Q4 FY2024, three months to 2024-12-31−$153.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(429)Operating income, Q1 FY2025, three months to 2025-03-31−$428.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(44.9)Operating income, Q2 FY2025, three months to 2025-06-30−$44.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure(38.9)Operating income, Q3 FY2025, three months to 2025-09-30−$38.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure(41.2)Operating income, Q4 FY2025, three months to 2025-12-31−$41.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(8.4)Operating income, Q1 FY2026, three months to 2026-03-31−$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(44.6)Operating income, Q2 FY2026, three months to 2026-06-30−$44.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Interest expense$m3.6Interest expense, Q3 FY2023, three months to 2023-09-30$3.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-03, accession 0001299130-23-000139.Report this figure3.6Interest expense, Q4 FY2023, three months to 2023-12-31$3.6m. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-02-28, accession 0001299130-24-000054. Derived: 12-month figure less the 9-month figure.Report this figure3.6Interest expense, Q1 FY2024, three months to 2024-03-31$3.6m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001299130-24-000111.Report this figure3.5Interest expense, Q2 FY2024, three months to 2024-06-30$3.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure3.5Interest expense, Q3 FY2024, three months to 2024-09-30$3.5m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure2.8Interest expense, Q4 FY2024, three months to 2024-12-31$2.8m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure1.7Interest expense, Q1 FY2025, three months to 2025-03-31$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure1.7Interest expense, Q2 FY2025, three months to 2025-06-30$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure1.7Interest expense, Q3 FY2025, three months to 2025-09-30$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure1.7Interest expense, Q4 FY2025, three months to 2025-12-31$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure1.7Interest expense, Q1 FY2026, three months to 2026-03-31$1.7m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure2.1Interest expense, Q2 FY2026, three months to 2026-06-30$2.1m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Income tax$m(10.7)Income tax, Q3 FY2023, three months to 2023-09-30−$10.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure(0.7)Income tax, Q4 FY2023, three months to 2023-12-31−$718.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure0.3Income tax, Q4 FY2024, three months to 2024-12-31$316.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(0.3)Income tax, Q1 FY2025, three months to 2025-03-31−$302.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$35.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure0.4Income tax, Q3 FY2025, three months to 2025-09-30$383.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure0.2Income tax, Q4 FY2025, three months to 2025-12-31$202.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure0.2Income tax, Q1 FY2026, three months to 2026-03-31$184.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$58.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Net income$m(66.9)Net income, Q3 FY2023, three months to 2023-09-30−$66.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure(82.0)Net income, Q4 FY2023, three months to 2023-12-31−$82.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(78.2)Net income, Q1 FY2024, three months to 2024-03-31−$78.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure(173)Net income, Q2 FY2024, three months to 2024-06-30−$173.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure(60.7)Net income, Q3 FY2024, three months to 2024-09-30−$60.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure2.4Net income, Q4 FY2024, three months to 2024-12-31$2.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(426)Net income, Q1 FY2025, three months to 2025-03-31−$426.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(41.9)Net income, Q2 FY2025, three months to 2025-06-30−$41.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure(38.0)Net income, Q3 FY2025, three months to 2025-09-30−$38.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure(40.4)Net income, Q4 FY2025, three months to 2025-12-31−$40.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(8.3)Net income, Q1 FY2026, three months to 2026-03-31−$8.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(44.7)Net income, Q2 FY2026, three months to 2026-06-30−$44.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Diluted EPS$ per share(0.26)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figurenot reported(0.29)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure(0.64)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure(0.22)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figurenot reported(1.44)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(0.14)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure(0.13)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figurenot reported(0.03)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(0.14)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Basic EPS$ per share(0.26)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.26 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figurenot reported(0.29)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.29 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure(0.64)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure(0.22)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.22 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figurenot reported(1.44)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(0.14)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure(0.13)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figurenot reported(0.03)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.03 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(0.14)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure

Balance sheet

Cash and equivalents$61.0m, Q2 FY2026
Shareholders' equity−$33.2m, Q2 FY2026
Pacific Biosciences of California, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m386Cash and equivalents, Q3 FY2023, at 2023-09-30$385.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure180Cash and equivalents, FY2023, at 2023-12-31$179.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001299130-26-000034.Report this figure76.6Cash and equivalents, Q1 FY2024, at 2024-03-31$76.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure99.5Cash and equivalents, Q2 FY2024, at 2024-06-30$99.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure78.0Cash and equivalents, Q3 FY2024, at 2024-09-30$78.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure55.4Cash and equivalents, FY2024, at 2024-12-31$55.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-02-25, accession 0001299130-26-000034.Report this figure58.5Cash and equivalents, Q1 FY2025, at 2025-03-31$58.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure54.8Cash and equivalents, Q2 FY2025, at 2025-06-30$54.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure56.5Cash and equivalents, Q3 FY2025, at 2025-09-30$56.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure63.7Cash and equivalents, FY2025, at 2025-12-31$63.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure56.3Cash and equivalents, Q1 FY2026, at 2026-03-31$56.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure61.0Cash and equivalents, Q2 FY2026, at 2026-06-30$61.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Current assets$m882Current assets, Q3 FY2023, at 2023-09-30$882.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-03, accession 0001299130-23-000139.Report this figure742Current assets, FY2023, at 2023-12-31$742.0m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0001299130-25-000061.Report this figure677Current assets, Q1 FY2024, at 2024-03-31$677.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001299130-24-000111.Report this figure628Current assets, Q2 FY2024, at 2024-06-30$628.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-09, accession 0001299130-24-000169.Report this figure584Current assets, Q3 FY2024, at 2024-09-30$584.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure496Current assets, FY2024, at 2024-12-31$495.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-02-25, accession 0001299130-26-000034.Report this figure445Current assets, Q1 FY2025, at 2025-03-31$444.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure413Current assets, Q2 FY2025, at 2025-06-30$413.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure394Current assets, Q3 FY2025, at 2025-09-30$394.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure375Current assets, FY2025, at 2025-12-31$375.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure370Current assets, Q1 FY2026, at 2026-03-31$369.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure339Current assets, Q2 FY2026, at 2026-06-30$338.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Total assets$m1,898Total assets, Q3 FY2023, at 2023-09-30$1.90bn. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-03, accession 0001299130-23-000139.Report this figure1,746Total assets, FY2023, at 2023-12-31$1.75bn. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0001299130-25-000061.Report this figure1,670Total assets, Q1 FY2024, at 2024-03-31$1.67bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001299130-24-000111.Report this figure1,509Total assets, Q2 FY2024, at 2024-06-30$1.51bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-09, accession 0001299130-24-000169.Report this figure1,450Total assets, Q3 FY2024, at 2024-09-30$1.45bn. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure1,260Total assets, FY2024, at 2024-12-31$1.26bn. XBRL concept us-gaap:Assets. 10-K filed 2026-02-25, accession 0001299130-26-000034.Report this figure861Total assets, Q1 FY2025, at 2025-03-31$860.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure825Total assets, Q2 FY2025, at 2025-06-30$825.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure803Total assets, Q3 FY2025, at 2025-09-30$803.2m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure784Total assets, FY2025, at 2025-12-31$784.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure782Total assets, Q1 FY2026, at 2026-03-31$782.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure752Total assets, Q2 FY2026, at 2026-06-30$751.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Current liabilities$m184Current liabilities, Q3 FY2023, at 2023-09-30$184.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-03, accession 0001299130-23-000139.Report this figure95.0Current liabilities, FY2023, at 2023-12-31$95.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-17, accession 0001299130-25-000061.Report this figure73.0Current liabilities, Q1 FY2024, at 2024-03-31$73.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001299130-24-000111.Report this figure78.4Current liabilities, Q2 FY2024, at 2024-06-30$78.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-09, accession 0001299130-24-000169.Report this figure60.0Current liabilities, Q3 FY2024, at 2024-09-30$60.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure66.3Current liabilities, FY2024, at 2024-12-31$66.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-02-25, accession 0001299130-26-000034.Report this figure66.6Current liabilities, Q1 FY2025, at 2025-03-31$66.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure59.8Current liabilities, Q2 FY2025, at 2025-06-30$59.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure63.2Current liabilities, Q3 FY2025, at 2025-09-30$63.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure72.8Current liabilities, FY2025, at 2025-12-31$72.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure65.4Current liabilities, Q1 FY2026, at 2026-03-31$65.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure68.8Current liabilities, Q2 FY2026, at 2026-06-30$68.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Total liabilities$m1,135Total liabilities, Q3 FY2023, at 2023-09-30$1.13bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-03, accession 0001299130-23-000139.Report this figure1,045Total liabilities, FY2023, at 2023-12-31$1.04bn. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-17, accession 0001299130-25-000061.Report this figure1,021Total liabilities, Q1 FY2024, at 2024-03-31$1.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001299130-24-000111.Report this figure1,017Total liabilities, Q2 FY2024, at 2024-06-30$1.02bn. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-09, accession 0001299130-24-000169.Report this figure997Total liabilities, Q3 FY2024, at 2024-09-30$996.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure754Total liabilities, FY2024, at 2024-12-31$753.9m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-02-25, accession 0001299130-26-000034.Report this figure769Total liabilities, Q1 FY2025, at 2025-03-31$769.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure764Total liabilities, Q2 FY2025, at 2025-06-30$764.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure767Total liabilities, Q3 FY2025, at 2025-09-30$767.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure779Total liabilities, FY2025, at 2025-12-31$778.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure780Total liabilities, Q1 FY2026, at 2026-03-31$780.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure785Total liabilities, Q2 FY2026, at 2026-06-30$785.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$mnot reported0.5Short-term borrowings, FY2023, at 2023-12-31$490.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2025-03-17, accession 0001299130-25-000061.Report this figurenot reportednot reportednot reported0.0Short-term borrowings, FY2024, at 2024-12-31$0. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2025-03-17, accession 0001299130-25-000061.Report this figurenot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m764Shareholders' equity, Q3 FY2023, at 2023-09-30$763.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure701Shareholders' equity, FY2023, at 2023-12-31$701.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-02-25, accession 0001299130-26-000034.Report this figure649Shareholders' equity, Q1 FY2024, at 2024-03-31$649.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure493Shareholders' equity, Q2 FY2024, at 2024-06-30$492.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure453Shareholders' equity, Q3 FY2024, at 2024-09-30$453.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure507Shareholders' equity, FY2024, at 2024-12-31$506.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure91.6Shareholders' equity, Q1 FY2025, at 2025-03-31$91.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure61.5Shareholders' equity, Q2 FY2025, at 2025-06-30$61.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure36.1Shareholders' equity, Q3 FY2025, at 2025-09-30$36.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure5.3Shareholders' equity, FY2025, at 2025-12-31$5.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure2.4Shareholders' equity, Q1 FY2026, at 2026-03-31$2.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure(33.2)Shareholders' equity, Q2 FY2026, at 2026-06-30−$33.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure

Cash flow

Operating cash flow−$35.6m, Q2 FY2026
Capital expenditure$1.6m, Q2 FY2026
Pacific Biosciences of California, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(65.2)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$65.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0001299130-24-000183. Derived: 9-month figure less the 6-month figure.Report this figure(57.6)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$57.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(75.7)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$75.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure(54.3)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$54.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-07, accession 0001299130-25-000156. Derived: 6-month figure less the 3-month figure.Report this figure(45.5)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$45.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001299130-25-000168. Derived: 9-month figure less the 6-month figure.Report this figure(30.7)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$30.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(44.1)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$44.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(29.4)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$29.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001299130-26-000122. Derived: 6-month figure less the 3-month figure.Report this figure(18.7)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$18.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001299130-25-000168. Derived: 9-month figure less the 6-month figure.Report this figure(19.1)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$19.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure(44.7)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$44.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure(35.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$35.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001299130-26-000122. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.8Capital expenditure, Q3 FY2023, three months to 2023-09-30$830.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0001299130-24-000183. Derived: 9-month figure less the 6-month figure.Report this figure2.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure3.9Capital expenditure, Q1 FY2024, three months to 2024-03-31$3.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure1.5Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-07, accession 0001299130-25-000156. Derived: 6-month figure less the 3-month figure.Report this figure(0.8)Capital expenditure, Q3 FY2024, three months to 2024-09-30−$787.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001299130-25-000168. Derived: 9-month figure less the 6-month figure.Report this figure1.6Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure1.4Capital expenditure, Q1 FY2025, three months to 2025-03-31$1.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure0.6Capital expenditure, Q2 FY2025, three months to 2025-06-30$550.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001299130-26-000122. Derived: 6-month figure less the 3-month figure.Report this figure(0.1)Capital expenditure, Q3 FY2025, three months to 2025-09-30−$86.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001299130-25-000168. Derived: 9-month figure less the 6-month figure.Report this figure0.9Capital expenditure, Q4 FY2025, three months to 2025-12-31$861.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-25, accession 0001299130-26-000034. Derived: 12-month figure less the 9-month figure.Report this figure3.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure1.6Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001299130-26-000122. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)310.65m, Q2 FY2026
Pacific Biosciences of California, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares225Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30225,123,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-03, accession 0001299130-23-000139.Report this figure242Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31242,032,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001299130-24-000111.Report this figure250Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30250,070,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-09, accession 0001299130-24-000169.Report this figure255Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30255,001,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-12, accession 0001299130-24-000183.Report this figure270Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31269,578,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001299130-25-000102.Report this figure272Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30272,385,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-07, accession 0001299130-25-000156.Report this figure273Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30272,915,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure297Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31296,858,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure300Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30300,162,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure301Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30300,844,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-06, accession 0001299130-25-000168.Report this figure306Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31305,819,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-08, accession 0001299130-26-000081.Report this figure311Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30310,655,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure

Shares outstanding: 310.83mShares outstanding, period not labelled, at 2026-07-31310,830,759 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001299130-26-000122.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. Listed shows no prices and gives no investment advice.